Clinics in dermatology最新文献

For more than 40 years, the editorial board of Clinics in Dermatology has been working behind the scenes to help our Editor-in-Chief, Dr Lawrence Charles Parish, bring to readers the best contributions in dermatology. Herein, we tell the story of the beginnings of Clinics in Dermatology and provide a list of the inaugural board members of which we highlight four: Drs Jean Civatte, John Thorne Crissey, Francisco Kerdal-Vegas, and Joseph A Witkowski. In addition, the board showcases our present 44 editorial board members including the Managing Editor Dr Hirak Behari Routh, our Senior Deputy Editors Dr Larry E Millikan and Dr Marcia Ramos-e-Silva, and our esteemed Chief Editor Dr Lawrence Charles Parish, and Chief Editor Designate, Dr Vinod E. Nambudiri. We are proud that all our editorial board members come with stellar academic achievements in dermatology and from all over the world. We are an active editorial board that works together, issue after issue, to provide the best in peer-review contributions and theme issues. The members look forward to continuing in this role for many years to come and they are grateful to our current publisher, Elsevier, and to our many authors and dear readers for their ongoing support and encouragement.

Oscar Samuel Hoffman (1856-1926) was the first Jewish physician to settle in Omaha, Nebraska in 1883. He taught dermatology for 25 years at the Omaha Medical College and University of Nebraska, after completing postgraduate work in Vienna under the noted dermatologist Moritz Kaposi (1837-1902). His expertise also included obstetrics, and he became the Professor of Obstetrics and Dermatology at Omaha Medical College. On July 14, 1913, Hoffman delivered Leslie Lynch King, Jr, better known by his later name, Gerald R. Ford, Jr, who became the 38th President of the United States in 1974. This contribution tells the story of that historic birth.

We commemorate and celebrate the historic careers and the medical and dermatologic contributions of seven distinguished European and Canadian Jewish women who were pioneers in dermatology. Although there may be other notable women, we have selected these dermatologists as examples of courage and determination. Each struggled to overcome professional barriers to women in medicine, and all had experienced antisemitism, especially those who fell under Nazi rule. We honor their achievements: Lili Farkas (1899-1992), Vera Shukhman (1900-1987), Stefania Jabłonska (1920-2017), Halina Szenicer-Rotstein (1907-1942), Fanny Cohn (1899-1990), Marie Caroline Kaufmann-Wolf (1877-1922), and Rickey Kanee Schachter (1918-2007).

Human trafficking is a global human rights violation affecting millions of individuals across diverse demographic characteristics with severe health consequences. Despite the frequent interactions that exploited individuals have with health care systems, many remain unrecognized, positioning health care providers, including dermatologists, as critical first responders. In the first part of this three-paper series, we discuss the current landscape of human trafficking from a health care perspective, emphasizing the role of dermatologists in recognizing and responding to this issue. This paper reviews the current understanding of trafficking, outlines the epidemiology and legal framework surrounding it, and discusses gaps in training for health care providers and policy that may hinder effective identification and intervention. It also explores state and national efforts to incorporate human trafficking education into health care training, emphasizing the need for standardized, trauma-informed approaches within dermatology. By fostering awareness and advocacy within the dermatology community, this paper aims to contribute to the broader efforts to combat human trafficking and improve the care and support provided to this patient population.

Clowns have long delighted circus crowds and are celebrated not only in popular culture but also in the dermatology literature as medical eponyms. This contribution discusses four such eponyms: (1) clown nose-like lesion, (2) clown eczema (perioral dermatitis), (3) clown alopecia pattern in frontal fibrosing alopecia, and (4) clown's face of Brachman de Lange syndrome (Cornelia de Lange syndrome). This contribution also highlights the role of medical clowning in patient care by paying tribute to Cobo the Clown, also known as Barbara Joyce Cohen, who has served as a dedicated caring clown for more than 30 years.

Patients experiencing or having experienced trafficking frequently interact with the health care system, highlighting the need for health care providers to be equipped with the appropriate tools to serve these patients effectively. The third part of this series focuses on navigating encounters with trafficked persons within the dermatology clinic, emphasizing the importance of trauma-informed, patient-centered care. We reviewed the barriers trafficked patients face and mechanisms to overcome them, the importance of comprehensive needs assessments, and the implementation of effective health care protocols. We additionally review the role of dermatologists in mandatory reporting and the use of appropriate International Classification of Diseases, Tenth Revision codes for documenting a potential trafficking victim encounter in the electronic medical record. We conclude with recommendations for specialized training, emphasizing the critical role dermatologists play in identifying and supporting trafficked patients within the health care system.

Human trafficking is a pervasive global health and human rights issue. The skin often bears the early and most visible signs of abuse and exploitation. Despite the visible nature of their trauma, affected patients frequently go unrecognized within health care settings due to a lack of standardized guidelines for identifying the dermatologic manifestations of trafficking. Herein, we address these challenges by equipping dermatologists and health care teams with the necessary tools to recognize, treat, and report the skin signs of human trafficking. In doing so, we hope to emphasize the importance of early identification and intervention, as well as bring awareness to critical signs, including dermatologic evidence of abuse, infectious diseases, sexually transmitted infections, substance use, and branding. In understanding this, we can bring awareness to dermatologists' critical role in caring for this patient population and their associated cutaneous manifestations. By advancing knowledge in this area, we hope to enhance the capacity of dermatologists to support trafficked individuals.

Dermatology is beginning to investigate the uses of virtual reality and augmented reality to enhance residency education and provide patients with comprehensive and interactive experiences. Although the applications of virtual reality and augmented reality to improve patient clinical care are exciting, these technologic advances may have implications for regulatory considerations, patient safety, informed consent, and privacy. We review how using artificial intelligence, virtual reality, and augmented reality can enhance patient care and deliberate the complex issues surrounding these potential innovations.